TOP TIERMARKET NEWSWIRE
News & sentiment

AN2 THERAPEUTICS INC (ANTX) — News & AI sentiment

AN2 THERAPEUTICS INC (ANTX) news roundup. 3 stories in the past week, 6 over 30 days. Average 30-day sentiment is 57.2/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $26K — net selling of $26K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 48.7/100
30d stories
6
avg sentiment 57.2/100
Insider net (90d)
$26K
0 buys · 2 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on ANTX

5d ago
5d ago
Jul 23
Jul 22
Jul 20
Guggenheim initiates AN2 Therapeutics stock with buy on PV drug
Investing.com Analyst Ratings61 · neutralanalyst
Jul 20
Jun 9
AN2 Therapeutics, Inc. (ANTX) files 8-K
SEC 8-K50 · neutralgeneral
Jun 8
Jun 4
Jun 4
Jun 4
May 21
Open ANTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →